Figure 2.
OS was assessed in BALB/c mice that underwent transplant with bone marrow transduced with FLT3-ITD and treated with midostaurin 100 mg/kg per day or placebo. Half of the mice were treated from days 30 to 88; the remaining mice were treated from days 25 to 68. Adapted from Weisberg et al46 with permission.
